Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 359 results for "mirati"

Mirati Therapeutics Prices Public Offering of Common Stock

SAN DIEGO, Jan. 29, 2015 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced the pricing of an underwritten public offering of 2,250,000 shares of its common stock, offered at a price to the public of $20.00 per share. The gross ... 4 Traders, 5 hours ago
[x]  

2 images for "mirati"

KXXV-TV, 3 hours ago
Pharmaceutical Business Review, 3 weeks ago

Mirati Therapeutics to launch public offering of common shares

Oncology company Mirati Therapeutics The company said it will provide the underwriters with a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering. Mirati Therapeutics added that there can ...
 BusinessWeek4 hours ago

SC 13G/A - Mirati Therapeutics, Inc. (0001576263) (Subject)

Document Format Files Seq Description Document Type Size 1 AMENDMENT NO. 1 f127150sc13ga1.htm SC 13G/A 122509 Complete submission text file
 SEC1 day ago 424B5 - Mirati Therapeutics, Inc. (0001576263) (Filer)  SEC21 hours ago

View: Will Pranab Mukherjee's book drop a bomb?

Poltu was born to a poor Brahmin family in a village called Mirati, 1935, in Birbhum district of West Bengal. His father, a schoolmaster, was frequently in and out of jail as he served the greater cause of Indian freedom from British colonialism.
 Economic Times1 month ago

Mirati Therapeutics Inc (MRTX) Jumps 5.43% on January 27

Mirati Therapeutics Inc ($MRTX) was among the biggest gainers on the Russell 2000 for Tuesday January 27 as the stock popped 5.43% to $20.98, representing a gain of $1.08 per share. Some 36,742 shares traded hands on 261 trades, compared with an ...
 Equities.com1 day ago Mirati Therapeutics Inc (MRTX) Drops 5.46% on January 21  Equities.com1 week ago Mirati Therapeutics Inc (MRTX) Hits New 52-week Low During December 01 Session  Equities.com1 month ago

Analysts Give $30.40 Consensus Price Target to Mirati Therapeutics (NASDAQ:MRTX)

Mirati Therapeutics (NASDAQ:MRTX) has been given a consensus broker rating score of 1.00 (Strong Buy) from the six brokers that cover the stock, Zacks Investment Research reports. Six research analysts have rated the stock with a strong buy rating.
 Ticker Report2 days ago Brokerages Anticipate Mirati Therapeutics to Post ($1.00) EPS (NASDAQ:MRTX)  Mideast Time1 week ago
Pharmaceutical Business Review

Mirati starts dosing in Phase II trial of mocetinostat to treat non-Hodgkin's lymphoma

US-based oncology firm Mirati Therapeutics has started dosing patients in an investigator-sponsored Phase II clinical trial of mocetinostat to treat relapsed and refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). The ...
 Pharmaceutical Business Review3 weeks ago MIRATI THERAPEUTICS : begins dosing in Phase II trial of mocetinostat to treat bladder cancer  4 Traders2 weeks ago Mirati begins dosing in Phase II trial of mocetinostat to treat bladder cancer  Pharmaceutical Business Review3 weeks ago Mirati Therapeutics : starts dosing in Phase II trial of mocetinostat to treat non-Hodgkin's lymphoma  4 Traders3 weeks ago

Mirati Therapeutics Price Target Raised to $37.00

Filed Under: Analysts Price Targets • Market News Research analysts at Piper Jaffray raised their price target on shares of Mirati Therapeutics (NASDAQ:MRTX) from $31.00 to $37.00 in a report released on Monday. The firm currently has an ...
 American Banking News1 month ago

Oversold Conditions For Mirati Therapeutics (MRTX)

at 13:20 PM EST Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called ...
 Fat Pitch Financials1 month ago
[x]  

Frontrunning: January 29

Who Doubts Yellen's Policies? Summers for One ( BBG ) Samsung, Apple Back in Dead Heat for Global Smartphone Dominance ( WSJ ) Islamic State purportedly sets new deadline for hostage swap ( Reuters ) Turkey's $7.9 Billion Mystery Money That's ...
 Zero Hedge5 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less